- Clinical & medical services
- Diagnostic clinical trial management
- Life cycle management of IVD devices
Innovative and novel in vitro diagnostics in virology and oncology based on DNA methylation marker and our proprietary exosome platform as next generation liquid biopsy.
“A CE-marked clinically validated biomarker assay”
The therascreen PITX2 RGQ PCR Kit has been developed by Therawis Diagnostics together with its development partner Qiagen using reliable RGQ PCR technology and routinely available FFPE tissue.
The therascreen PITX2 RGQ PCR Kit is CE-certified and commercially available since February 2018.